Back to search

National and Kapodistrian University of Athens

Development and clinical application of methods for the molecular characterisation of circulating tumour cells (CTCs)

Abstract

dc:description

Molecular information extracted from circulating tumour cells (CTCs) and circulating tumour DNA(ctDNA), the so-called “liquid biopsy”, offers the possibility to characterise the evolution of a solidtumour in real time and is really helpful for diagnostic and therapeutic purposes. Epigenetic silencing of tumour and metastasis suppressor genes plays a key role in survival and metastatic potential of cancer cells. The aim of the present study was the development and validation of analytical methods for the molecular characterisation of CTCs based on the liquid bead array technology and their application in clinical samples of breast cancer patients. In the present study we developed and evaluated a multiplex PCR-coupled liquid bead array (MLBA) assay for studying simultaneously the expression of the following 14 genes: ALDH1, CD24, CD44, CK19, HER2, hMAM, MAGEA3, PDCD4, PTEN, SNAIL, TWIST, VIM, and PBGD and HPRT as reference genes. The MLBA assay was characterised by high analytical specificity and sensitivity, and reproducibility. The analytical performance of the MLBA assay was compared with a commercially available test (AdnaTest BreastCancer) and our previously established multiplex RT-qPCR assay. The developed assay has the potential to be further expanded in order to include more established targets, e.g.genes correlated with therapy response. We also developed and evaluated a multiplex methylation specific PCR-coupled liquid bead array (MMSPA) assay for detecting simultaneously the promoters methylation status of three tumour and metastasis suppressors, CST6, SOX17 and BRMS1, in CTCs, ctDNA and paired primary breast tumours. The developed assay was characterised by high analytical specificity, sensitivity and reproducibility. The analytical performance of the MMSPA assay was compared with our previously established single qMSP assays. The main principle of the developed methodology has the potential to be extended in a large number of genes-targets and could be applied in many different types of cancer. In the present study, we tried to compare our well established RT-qPCR assay for the detection of CK19 and the protein-based EPISPOT technique for CTCs detection. These two methods gave similar results in terms of samples positivity but cannot be substantially compared in terms of absolute quantification as they represent different detection approaches. A much more essential comparison of the two methods would be the investigation of their correlation in terms of CTC-positivity in patients’ samples.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Parisi, Cleo
  • Παρίση, Κλειώ

Subjects

dc:subject × 18

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47043

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Parisi, Cleo; Παρίση, Κλειώ. Development and clinical application of methods for the molecular characterisation of circulating tumour cells (CTCs). National and Kapodistrian University of Athens, 2016. http://hdl.handle.net/10442/hedi/47043